A randomized, controlled study of a simple, once-daily regimen of dihydroartemisinin-piperaquine for the treatment of uncomplicated, multidrug-resistant falciparum malaria.

A randomized, controlled study of a simple, once-daily regimen of dihydroartemisinin-piperaquine for the treatment of uncomplicated, multidrug-resistant falciparum malaria.

BACKGROUND: Dihydroartemisinin-piperaquine (DP) is a fixed-combination antimalarial drug increasingly deployed in Southeast Asia. The current regimen involves 4 doses given over 3 days. Simplification of the dose regimen should facilitate treatment adherence and thereby increase effectiveness. METH...

Täydet tiedot

Bibliografiset tiedot
Päätekijät: Ashley, E, Mcgready, R, Hutagalung, R, Phaiphun, L, Slight, T, Proux, S, Thwai, K, Barends, M, Looareesuwan, S, White, N, Nosten, F
Aineistotyyppi: Journal article
Kieli:English
Julkaistu: 2005

Samankaltaisia teoksia

Samankaltaisia teoksia